论文部分内容阅读
非小细胞肺癌（Non－SmallCellLungCancerNSCLC）占所有肺癌的80％。对I、II期和部分IIIa。期的病人首选外科手术治疗或以外科为主的综合治疗；对部分Ill。期和IIIb期的病人选择放疗或化放综合治疗；对IV期的病人以化疗为主，偶尔为减轻症状或姑息目的辅以放疗。目前生物治疗或
Non-Small Cell Lung Cancer NSCLC accounts for 80% of all lung cancers. For Phases I, II, and IIIa. Patients in the period of treatment preferred surgical treatment or surgery-based comprehensive treatment; for part Ill. The patients in phase IIIb and phase IIIb chose radiotherapy or chemotherapy combined chemotherapy; the patients in phase IV were treated with chemotherapy, and occasionally used to relieve symptoms or palliative purposes supplemented by radiotherapy. Current biotherapy or